Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
7528 | 1358 | 42.7 | 85% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
6 | 4 | GASTROENTEROLOGY & HEPATOLOGY//ONCOLOGY//SURGERY | 1371034 |
216 | 3 | NON SMALL CELL LUNG CANCER//LUNG CANCER//THORAC SURG | 51214 |
1612 | 2 | SMALL CELL LUNG CANCER//BOMBESIN//GASTRIN RELEASING PEPTIDE | 7087 |
7528 | 1 | SW MED SIMMONS CANC//LUNG CANCER//K RAS GENOTYPES | 1358 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | SW MED SIMMONS CANC | address | 71947 | 0% | 80% | 4 |
2 | LUNG CANCER | authKW | 71594 | 18% | 1% | 246 |
3 | K RAS GENOTYPES | authKW | 67452 | 0% | 100% | 3 |
4 | NON SMALL CELL LUNG CANCER | authKW | 46034 | 10% | 1% | 141 |
5 | ETIOL CHEM CARCINOGENESIS | address | 44968 | 0% | 100% | 2 |
6 | P185HER 2 | authKW | 44968 | 0% | 100% | 2 |
7 | SOMATIC GENETIC CHANGES | authKW | 44968 | 0% | 100% | 2 |
8 | INVEST CLIN ONCOL EXPT HJ TAGNON | address | 31220 | 0% | 28% | 5 |
9 | CLIN SCI K4 666 | address | 29977 | 0% | 67% | 2 |
10 | LUNG CANC BASIC PROGRAM | address | 29977 | 0% | 67% | 2 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Oncology | 22076 | 65% | 0% | 884 |
2 | Respiratory System | 5460 | 17% | 0% | 229 |
3 | Pathology | 1160 | 9% | 0% | 120 |
4 | Genetics & Heredity | 1080 | 13% | 0% | 175 |
5 | Critical Care Medicine | 270 | 3% | 0% | 42 |
6 | Cell Biology | 133 | 7% | 0% | 97 |
7 | Medical Laboratory Technology | 29 | 1% | 0% | 14 |
8 | Medicine, General & Internal | 25 | 4% | 0% | 52 |
9 | Medicine, Research & Experimental | 23 | 3% | 0% | 38 |
10 | Biochemistry & Molecular Biology | 18 | 8% | 0% | 112 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | SW MED SIMMONS CANC | 71947 | 0% | 80% | 4 |
2 | ETIOL CHEM CARCINOGENESIS | 44968 | 0% | 100% | 2 |
3 | INVEST CLIN ONCOL EXPT HJ TAGNON | 31220 | 0% | 28% | 5 |
4 | CLIN SCI K4 666 | 29977 | 0% | 67% | 2 |
5 | LUNG CANC BASIC PROGRAM | 29977 | 0% | 67% | 2 |
6 | NUTRIT BIOCHEM MOL BIOL | 29977 | 0% | 67% | 2 |
7 | AFFILIATED HOSP 1 THORAC SURG | 22484 | 0% | 100% | 1 |
8 | ALBERT BENNIOTLUNG CANC GRP | 22484 | 0% | 100% | 1 |
9 | ANATBRAIN KOREA BIOMED SCI 21 | 22484 | 0% | 100% | 1 |
10 | AOS PAULO | 22484 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | LUNG CANCER | 37531 | 6% | 2% | 86 |
2 | CANCER GENETICS AND CYTOGENETICS | 9910 | 4% | 1% | 52 |
3 | GENES CHROMOSOMES & CANCER | 7223 | 2% | 1% | 32 |
4 | CANCER RESEARCH | 4992 | 7% | 0% | 94 |
5 | ANTICANCER RESEARCH | 3237 | 4% | 0% | 53 |
6 | CLINICAL CANCER RESEARCH | 3143 | 3% | 0% | 46 |
7 | BRITISH JOURNAL OF CANCER | 2593 | 3% | 0% | 46 |
8 | INTERNATIONAL JOURNAL OF ONCOLOGY | 2222 | 2% | 0% | 31 |
9 | ONCOLOGY REPORTS | 1734 | 2% | 0% | 28 |
10 | ONCOGENE | 1304 | 2% | 0% | 33 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | LUNG CANCER | 71594 | 18% | 1% | 246 | Search LUNG+CANCER | Search LUNG+CANCER |
2 | K RAS GENOTYPES | 67452 | 0% | 100% | 3 | Search K+RAS+GENOTYPES | Search K+RAS+GENOTYPES |
3 | NON SMALL CELL LUNG CANCER | 46034 | 10% | 1% | 141 | Search NON+SMALL+CELL+LUNG+CANCER | Search NON+SMALL+CELL+LUNG+CANCER |
4 | P185HER 2 | 44968 | 0% | 100% | 2 | Search P185HER+2 | Search P185HER+2 |
5 | SOMATIC GENETIC CHANGES | 44968 | 0% | 100% | 2 | Search SOMATIC+GENETIC+CHANGES | Search SOMATIC+GENETIC+CHANGES |
6 | SQUAMOUS CELL CARCINOMAS OF THE LUNG | 29977 | 0% | 67% | 2 | Search SQUAMOUS+CELL+CARCINOMAS+OF+THE+LUNG | Search SQUAMOUS+CELL+CARCINOMAS+OF+THE+LUNG |
7 | P53 | 27033 | 11% | 1% | 148 | Search P53 | Search P53 |
8 | SQUAMOUS CELL LUNG CARCINOMA | 23938 | 1% | 15% | 7 | Search SQUAMOUS+CELL+LUNG+CARCINOMA | Search SQUAMOUS+CELL+LUNG+CARCINOMA |
9 | LOSS OF HETEROZYGOSITY | 23718 | 3% | 2% | 47 | Search LOSS+OF+HETEROZYGOSITY | Search LOSS+OF+HETEROZYGOSITY |
10 | 3P221 | 22484 | 0% | 100% | 1 | Search 3P221 | Search 3P221 |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | MITSUDOMI, T , HAMAJIMA, N , OGAWA, M , TAKAHASHI, T , (2000) PROGNOSTIC SIGNIFICANCE OF P53 ALTERATIONS IN PATIENTS WITH NON-SMALL CELL LUNG CANCER: A META-ANALYSIS.CLINICAL CANCER RESEARCH. VOL. 6. ISSUE 10. P. 4055 -4063 | 57 | 75% | 190 |
2 | STEELS, E , PAESMANS, B , BERGHMANS, T , BRANLE, F , LEMAITRE, F , MASCAUX, C , MEERT, AP , VALLOT, F , LAFITTE, JJ , SCULIER, JP , (2001) ROLE OF P53 AS A PROGNOSTIC FACTOR FOR SURVIVAL IN LUNG CANCER: A SYSTEMATIC REVIEW OF THE LITERATURE WITH A META-ANALYSIS.EUROPEAN RESPIRATORY JOURNAL. VOL. 18. ISSUE 4. P. 705-719 | 63 | 60% | 238 |
3 | TAMMEMAGI, MC , MCLAUGHLIN, JR , BULL, SB , (1999) META-ANALYSES OF P53 TUMOR SUPPRESSOR GENE ALTERATIONS AND CLINICOPATHOLOGICAL FEATURES IN RESECTED LUNG CANCERS.CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION. VOL. 8. ISSUE 7. P. 625 -634 | 66 | 72% | 50 |
4 | GAO, WM , JIN, JD , YIN, JL , LAND, S , GAITHER-DAVIS, A , CHRISTIE, N , LUKETICH, JD , SIEGFRIED, JM , KEOHAVONG, P , (2017) KRAS AND TP53 MUTATIONS IN BRONCHOSCOPY SAMPLES FROM FORMER LUNG CANCER PATIENTS.MOLECULAR CARCINOGENESIS. VOL. 56. ISSUE 2. P. 381 -388 | 41 | 68% | 0 |
5 | ZHANG, J , WANG, SF , WANG, L , WANG, R , CHEN, SF , PAN, B , SUN, YH , CHEN, HQ , (2015) PROGNOSTIC VALUE OF BCL-2 EXPRESSION IN PATIENTS WITH NON-SMALL-CELL LUNG CANCER: A META-ANALYSIS AND SYSTEMIC REVIEW.ONCOTARGETS AND THERAPY. VOL. 8. ISSUE . P. 3361 -3369 | 37 | 73% | 3 |
6 | BRECHOT, JM , MOLINA, T , THEOBALD, S , DEPIERRE, A , LAGRANGE, JL , ASTOUL, P , BALDEYROU, P , BARDET, E , BAZELLY, B , BRETON, JL , ET AL (2002) 2000 STANDARDS, OPTIONS AND RECOMMENDATIONS FOR PROGNOSTIC VALUE OF ONCOGENES AND TUMOR SUPPRESSOR GENES IN NON SMALL CELL LUNG CANCER.BULLETIN DU CANCER. VOL. 89. ISSUE 10. P. 857-867 | 41 | 89% | 1 |
7 | LIU, LX , SHAO, XY , GAO, W , BAI, JL , WANG, RS , HUANG, PW , YIN, YM , LIU, P , SHU, YQ , (2010) THE ROLE OF HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR 2 AS A PROGNOSTIC FACTOR IN LUNG CANCER A META-ANALYSIS OF PUBLISHED DATA.JOURNAL OF THORACIC ONCOLOGY. VOL. 5. ISSUE 12. P. 1922 -1932 | 45 | 53% | 40 |
8 | TESTA, JR , LIU, ZM , FEDER, M , BELL, DW , BALSARA, B , CHENG, JQ , TAGUCHI, T , (1997) ADVANCES IN THE ANALYSIS OF CHROMOSOME ALTERATIONS IN HUMAN LUNG CARCINOMAS.CANCER GENETICS AND CYTOGENETICS. VOL. 95. ISSUE 1. P. 20-32 | 58 | 60% | 77 |
9 | CAMPLING, BG , EL-DEIRY, WS , (2003) CLINICAL IMPLICATION OF P53 MUTATION IN LUNG CANCER.MOLECULAR BIOTECHNOLOGY. VOL. 24. ISSUE 2. P. 141-156 | 60 | 51% | 32 |
10 | HILBE, W , DIRNHOFER, S , GREIL, R , WOLL, E , (2004) BIOMARKERS IN NON-SMALL CELL LUNG CANCER PREVENTION.EUROPEAN JOURNAL OF CANCER PREVENTION. VOL. 13. ISSUE 5. P. 425-436 | 71 | 41% | 26 |
Classes with closest relation at Level 1 |